ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP

BAUDETTE, Minn., Jan. 16, 2020 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and... Biopharmaceuticals, Generics, FDA ANI Pharmaceuticals, Potassium Citrate
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news